Navigation Links
Cholesterol Metabolism Linked to HIV Progression
Date:7/17/2015

Cholesterol Metabolism in Immune Cells Linked to HIV Progression, May Lead to New Therapy

Enhanced cholesterol metabolism in certain immune cells may help some people infected with HIV naturally control disease progression, according to new research from the University of Pittsburgh Graduate School of Public Health.

The findings – funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health (NIH) and presented today at the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment & Prevention in V ancouver – provides a basis for potential development of new approaches to control HIV infection by regulating cellular cholesterol metabolism.

“We’ve known for two decades that some people don’t have the dramatic loss in their T cells and progression to AIDS that you’d expect without drug therapy,” said lead author Giovanna Rappocciolo, Ph.D., an assistant professor in Pitt Public Health’s Department of Infectious Diseases and Microbiology. “Instead, the disease progresses more slowly, and we believe altered cholesterol metabolism in certain immune cells may be a reason.”

Immune cells known as antigen-presenting cells (APCs) can deliver HIV to its primary target – T cells – through a process known as trans infection. HIV then uses T cells as its main site of replication. It is through this mechanism that levels of HIV increase and overwhelm the immune system, leading to AIDs.

However, some HIV-infected people do not progress to AIDS for many years, even without antiretroviral therapy, because their APCs do not effectively trans infect T cells. These people are known as “nonprogressors.” A closer look revealed that this defect in trans infection is likely due to altered cholesterol metabolism within the APCs, which appears to be an inherited trait.

This discovery was made possible by using 30 years of data and biologic specimens collected through the NIH-funded Multicenter AIDS Cohort Study (MACS), a confidential research study of the natural history of untreated and treated HIV/AIDS in men who have sex with men. The Pittsburgh arm of the study is the Pitt Men’s Study.

Dr. Rappocciolo and her colleagues searched for patterns in gene expression, or the degree to which specific genes are turned on or off, in APCs from eight HIV nonprogressors and eight progressors enrolled in MACS.

“Compared to APCs from progressors, cells from nonprogressors expressed higher levels of several cholesterol-related genes associated with defective trans infection,” Dr. Rappocciolo said. “These results improve understanding of how nonprogressors control HIV without drug therapy and potentially may contribute to new approaches to manage HIV infection.”

Additional researchers on this work are Charles Rinaldo, Ph.D., Jeremy Martinson, D. Phil., Diana Campbell, B.S., and Maureen McGowan, B.S., all of Pitt Public Health.

This research was supported by NIH grants R01-AI118403-01, U01-AI35041 and R37-AI41870.

# # #

Contact: Allison Hydzik
Phone: 412-647-9975
E-mail: HydzikAM(at)upmc(dot)edu

Contact: Wendy Zellner
Phone: 412-586-9777
E-mail: ZellnerWL(at)upmc(dot)edu

Read the full story at http://www.prweb.com/releases/2015/07/prweb12851264.htm.


'/>"/>
Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related medicine news :

1. NutritionInstructorMD Presents New Ways on How to Manage Cholesterol
2. Myths About Cholesterol-Lowering Statins - February 2015 Harvard Heart Letter
3. Bel Marra Health Reports on Cholesterol-Lowering Power of Avocados
4. Lipitor Lawsuit Filings Alleging The Development of Type 2 Diabetes After Using The Cholesterol Lowering Medication Continue To Rise, Wright & Schulte LLC Reports
5. Nearly All Diabetics Should Be on Cholesterol-Lowering Drugs: Experts
6. Lipitor Lawsuit News: Bernstein Liebhard LLP Notes New Study Suggesting a Possible Alternative to Cholesterol-Lowering Statins
7. Cholesterol Drug Vytorin Linked to Reduced Heart Attack Risk
8. Experimental Cholesterol-Lowering Drug Effective, Study Reports
9. Diet Doc Announces Updated Medical Weight Loss Programs that Teach Patients How to Lower Bad Cholesterol Levels with Safe, Healthy and Fast Weight Loss
10. High Cholesterol Tied to Prostate Cancers Return in Study
11. Gastric bypass bests banding for weight loss, diabetes, high blood pressure and cholesterol control
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2019)... Mass. (PRWEB) , ... May 23, 2019 , ... ... the healthcare industry, today announced that Lean Human Capital has selected the winners ... ninth year Lean Human Capital by HealthcareSource has recognized excellence in healthcare recruitment. ...
(Date:5/23/2019)... ... May 23, 2019 , ... Neurohacker Collective , the ... Emerson Ecologics. Qualia Mind, Qualia Focus, and Qualia Mind Caffeine Free are now ... extensive nearly 40 year history of providing the broadest selection of wellness products, ...
(Date:5/22/2019)... ... ... 5 Design Change Considerations to Stay Compliant , An FDAnews Webinar, Thursday, ... devicemakers read the fine print when changing a design? , Changes are subject to ... t’s may result in inspection failures as well as missed profit opportunities. , Spend ...
(Date:5/22/2019)... ... 22, 2019 , ... In the U.S. in 2014, according to the Society ... last step in the in vitro fertilization (IVF) process. This represents an 83% increase ... P. Trolice, Director of Fertility CARE: The IVF Center , emphasizes that donated ...
(Date:5/22/2019)... , ... May 22, 2019 , ... With record-breaking starting positions, three drivers from ... Ed Jones have qualified their Chevrolets for the team’s entry in the 103rd ... NTT IndyCar Series qualifying run, Pigot was sitting in pole position in his No. 21 ...
Breaking Medicine News(10 mins):
(Date:5/23/2019)... Wash. (PRWEB) , ... May 23, 2019 , ... PROSHRED® ... from 9AM to 12PM in partnership with The American Institute for Cancer Research (AICR). ... funds for cancer research. The event will be held at PROSHRED® Seattle’s location - ...
(Date:5/23/2019)... (PRWEB) , ... May 23, 2019 , ... ... at its multispecialty and primary-care facilities. “Our philosophy is to provide the highest ... Eric Avezzano, CEO and managing partner of Bergen Medical Associates. “We offer a ...
(Date:5/22/2019)... EDWARDSVILLE, Ill. (PRWEB) , ... May 22, 2019 , ... ... School of Pharmacy (SOP). Luer has served as interim dean since July ... School of Pharmacy has continued its outstanding record of accomplishment during Dr. Luer’s service ...
Breaking Medicine Technology: